News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Robbins Andrew R
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/24/2022 |
4
| Robbins Andrew R (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $2.01, valued at
$20.4k
|
|
| 01/27/2022 |
4
| Robbins Andrew R (President and CEO) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 690,000 options to buy
@ $7.6, valued at
$5.2M
|
|
| 05/14/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2020 |
4
| Robbins Andrew R (President and CEO) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 456,693 options to buy
@ $12.76, valued at
$5.8M
|
|
| 10/27/2020 |
4
| Robbins Andrew R (President and CEO) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 7,442,421 options to buy
@ $2.79, valued at
$20.8M
|
|
| 10/27/2020 |
3
| Robbins Andrew R (President and CEO) has filed a Form 3 on Cogent Biosciences, Inc. |
| 10/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/01/2020 |
4
| Robbins Andrew R (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 20,335 options to buy
@ $11.78, valued at
$239.5k
|
|
| 04/01/2020 |
3
| Robbins Andrew R (Director) has filed a Form 3 on Harpoon Therapeutics, Inc. |
| 07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2019 |
4
| Robbins Andrew R (COO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 8,660 shares
@ $24.6, valued at
$213k
Exercised 9,844 restricted stock units
@ $0 |
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2018 |
4
| Robbins Andrew R (COO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 11,898 shares
@ $15.97, valued at
$190k
Granted 52,625 restricted stock units
@ $0
Granted 315,750 options to buy
@ $15.97, valued at
$5M
Exercised 13,083 restricted stock units
@ $0
Exercised 13,968 restricted stock units
@ $0 |
|
| 06/29/2018 |
4
| Robbins Andrew R (COO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 14,104 shares
@ $18.5, valued at
$260.9k
Sold 17,964 shares
@ $17.74, valued at
$318.7k
Exercised 32,068 restricted stock units
@ $0 |
|
| 04/03/2018 |
4
| Robbins Andrew R (COO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 8,675 shares
@ $16.32, valued at
$141.6k
Exercised 9,844 restricted stock units
@ $0 |
|
| 12/19/2017 |
4
| Robbins Andrew R (COO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 6,094 shares
@ $10.92, valued at
$66.5k
Sold 282,874 shares
@ $10.72, valued at
$3M
Exercised 13,082 restricted stock units
@ $0
Granted 55,875 restricted stock units
@ $0
Granted 335,250 options to buy
@ $10.92, valued at
$3.7M
Exercised 200,000 options to buy
@ $5.14, valued at
$1M
Exercised 20,366 options to buy
@ $4.91, valued at
$100k
Exercised 89,634 options to buy
@ $4.91, valued at
$440.1k
Exercised 87,500 options to buy
@ $4.63, valued at
$405.1k
|
|
| 04/06/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/30/2013 |
3
| Robbins Andrews R (SVP, Commercial Operations) has filed a Form 3 on ARRAY BIOPHARMA INC |
|
|